CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it has granted equity awards to 76 new non-executive employees as part of its 2025 Inducement Plan. The awards were approved by the company’s independent Compensation Committee under Nasdaq Listing Rule 5635(c)(4).
The grants include options to purchase 2,015 shares of common stock at an exercise price of $425.60 per share, matching the closing price on September 15, 2025. Vesting for the options begins with 25% on the first anniversary of the grant, followed by 6.25% each quarter thereafter. In addition, employees received 31,821 restricted stock units that will vest in equal installments over four years, contingent on continued employment.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.